Here's How Boston Scientific Is Expanding Its Global Growth

BSX expands global reach with strong APAC growth, FARAPULSE momentum and new approvals driving gains across Europe and China.

Zacks Investment Research • 9 hours ago

Should You Buy, Hold or Sell BSX Stock Amid Cardiovascular Boom?

Boston Scientific rides on cardiovascular device growth with FARAPULSE and WATCHMAN momentum, but margin pressure and weaker estimates cloud the outlook.

Zacks Investment Research • May 13, 2026

Belo Sun to Commence Technical Studies on Volta Grande Gold Project

TORONTO, May 12, 2026 (GLOBE NEWSWIRE) -- Belo Sun Mining Corp. (“Belo Sun” or “Company”) (TSX: BSX, OTCQB: BSXGF) today announces the commencement of technical studies relating to its Volta Grande Gold Project (“Project”) located in Pará State, Brazil, with the engagement of a mining consultant and the hiring of a Engineering Director.

GlobeNewsWire • May 12, 2026

Boston Scientific: Poised To Rebound With The Healthcare Sector, But When?

Boston Scientific Corporation is a leading medtech innovator facing recent share price underperformance due to market share erosion in electrophysiology and sector-wide sentiment shifts. Despite competitive pressures, BSX maintains strong leadership in PFA, with Watchman and neuromodulation as promising growth drivers and a robust pipeline supported by strategic M&A. Management has improved operating and net margins, reduced short-term debt, and achieved ROIC above WACC, signaling efficient capital allocation and resilience despite slowing revenue growth.

Seeking Alpha • May 11, 2026

BSX Q1 Neuromodulation Sales Rise 15% Y/Y: What Lies Behind the Growth?

Boston Scientific's Neuromodulation unit posts 15% organic sales growth in Q1, fueled by pain management gains, the acquisition of Nalu and momentum in Intracept.

Zacks Investment Research • May 8, 2026

Allspring Large Cap Growth Fund Q1 2026 Attribution And Adjustments

Quanta Services, Inc. stock performed well during the quarter following a strong earnings beat, record backlog, and growing recognition that power infrastructure has become a critical bottleneck in the build-out of AI. Vertiv Holdings Co. benefited from a sharp acceleration of growth in its order book and continued ability to win market share from legacy players in the cooling space. During the quarter, EMCOR Group, Inc. reported record results that underscored strong execution and demand across core end markets.

Seeking Alpha • May 8, 2026

US FDA issues recall of Boston Scientific heart devices

Boston Scientific has issued an urgent recall to correct several heart devices after the U.S. Food ​and Drug Administration classified the action as its ‌most serious recall, the regulator said on Thursday.

Reuters • May 7, 2026

Belo Sun Mining Corp. Begins Trading on OTCQX

TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- Belo Sun Mining Corp. (“Belo Sun” or the “Company”) (TSX: BSX; OTCQX: BSXGF) is pleased to announce that effective today, its common shares have qualified to trade on the OTCQX® Best Market (“OTCQX”) in the United States under the ticker “BSXGF”. The Company's common shares will continue to trade on the TSX Exchange under the symbol “BSX”.

GlobeNewsWire • May 7, 2026

Diamond Hill Small-Mid Cap Strategy Q1 2026 Portfolio Activity

We do not believe Humana's current share price reflects the company's earnings power, and as industry conditions normalize, we believe it can return to target margins over the long term. We initiated a position in Antero Resources, a natural gas exploration and production company, to gain exposure given our constructive long-term outlook for US natural gas. We exited our position in First Advantage, a leader in the background check space, to pursue other opportunities with less macro exposure and AI-disruption concerns.

Seeking Alpha • May 7, 2026

Penumbra, Inc. Reports First Quarter 2026 Financial Results

ALAMEDA, Calif., May 6, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the first quarter ended March 31, 2026.

PRNewsWire • May 6, 2026